QUINTILES
Quintiles helps pharmaceutical, biotechnology and medical device companies develop and market innovative therapies. What drives us: the promise of medical breakthroughs that will improve and save lives. They invite you to explore the possibilities of partnering with Quintiles throughout the product lifecycle.
QUINTILES
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1982-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.quintiles.com
Total Employee:
10001+
Status:
Active
Total Funding:
3.53 B USD
Technology used in webpage:
SPF SSL By Default Font Awesome Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 JsDelivr Microsoft Azure DNS
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Current Advisors List
Jack M. Greenberg Board of Director @ Quintiles Board_member
Andrew Schiff Board of Directors @ Quintiles Board_member
Leonard D. Schaeffer Board of Director @ Quintiles Board_member
Michael J. Evanisko Board of Director @ Quintiles Board_member
Jonathan Coslet Board of Director @ Quintiles Board_member
Elke Roschmann Senior Scientific Advisor, Strategic Drug Development @ Quintiles Advisor
John Connaughton Board of Director @ Quintiles Board_member
Annie Hai-yuan Lo Board of Director @ Quintiles Board_member
Current Employees Featured
John Leonard
John Leonard Board of Director @ Quintiles Board of Director
Laurence Perreault Levasseur
Laurence Perreault Levasseur Senior Director @ Quintiles Senior Director
Margaret Keegan
Margaret Keegan President, Data Sciences, Safety and Regulatory @ Quintiles President, Data Sciences, Safety and Regulatory
Slawek Wojtowicz
Slawek Wojtowicz Senior Medical Director @ Quintiles Senior Medical Director 2014-05-01
Ross Horsburgh
Ross Horsburgh Senior Vice President, Deputy Head, Asia Pacific @ Quintiles Senior Vice President, Deputy Head, Asia Pacific
Brian Kelly
Brian Kelly President, Payer & Provider Solutions @ Quintiles President, Payer & Provider Solutions
Alejandro Martinez
Alejandro Martinez Chief Information Officer @ Quintiles Chief Information Officer
Andrea Spannheimer
Andrea Spannheimer Global Head, Real-World & Late Phase Research @ Quintiles Global Head, Real-World & Late Phase Research
Jeffrey Spaeder
Jeffrey Spaeder Chief Medical and Scientific Officer @ Quintiles Chief Medical and Scientific Officer
Elgar Peerschke
Elgar Peerschke President, Advisory Services @ Quintiles President, Advisory Services
Founder
Dennis Gillings
Gary Koch
Stock Details
Company's stock symbol is NASDAQ:Q
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2014-07-01 | Encore Health Resources | Encore Health Resources acquired by Quintiles | N/A |
2013-09-16 | Novella | Novella acquired by Quintiles | N/A |
2012-08-13 | Expression Analysis | Expression Analysis acquired by Quintiles | N/A |
2011-10-26 | Advion Inc. | Advion Inc. acquired by Quintiles | N/A |
2011-10-19 | VCG & Associates | VCG & Associates acquired by Quintiles | N/A |
2011-10-19 | Outcome Sciences | Outcome Sciences acquired by Quintiles | N/A |
2008-12-01 | Targeted Molecular Diagnostics | Targeted Molecular Diagnostics acquired by Quintiles | N/A |
2008-05-07 | Eidetics | Eidetics acquired by Quintiles | N/A |
2007-10-30 | Bio-Trials | Bio-Trials acquired by Quintiles | N/A |
2002-10-29 | Health Research Solutions | Health Research Solutions acquired by Quintiles | N/A |
Investors List
3i Group
3i Group investment in Private Equity Round - Quintiles
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2006-04-11 | Bayhill Therapeutics | Quintiles investment in Venture Round - Bayhill Therapeutics | 15.8 M USD |
2005-05-04 | Bayhill Therapeutics | Quintiles investment in Series B - Bayhill Therapeutics | 35.4 M USD |
2001-10-16 | D Pharm LTD. | Quintiles investment in Series D - D Pharm LTD. | 30 M USD |
2001-06-13 | NitroMed | Quintiles investment in Series E - NitroMed | 31.4 M USD |
Newest Events participated
Participated in Early Clinical Development 2017
on 2017-11-28 as sponsor
Participated in Partnerships in Clinical Trials Europe 2017
on 2017-11-28 as sponsor
Official Site Inspections
http://www.quintiles.com Semrush global rank: 60.29 K Semrush visits lastest month: 1.92 M
- Host name: 162.44.221.155
- IP address: 162.44.221.155
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ...